1 French Clozapine Task Force; Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team pharmacoepidemiology, UMR 1219, F-33000 Bordeaux, France.
2 Goethe University Frankfurt, University Hospital, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Germany.
3 Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, University of Augsburg, Augsburg, Germany.
4 DZPG (German Center for Mental Health), partner site Munich/Augsburg, Germany.
5 Evidence-based Psychiatry and Psychotherapy, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
6 French Clozapine Task Force; ACPPA group, F-69340 Francheville; Hospices Civils de Lyon, Hôpital des Charpennes, F-69100 Villeurbanne; Institut des Sciences Cognitives Marc Jeannerod, CNRS, Team Neuroplasticity in Parkinson's disease, UMR 5229, F-69500 Bron, France.
7 Department of Psychiatry, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
8 Department of Child and Adolescent Psychiatry, Ulm University, Germany.
9 Department of Hospital Pharmacy, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
10 Mental health Organization Rivierduinen, Leiden, The Netherlands.
11 Department of Psychiatry, University Medical Centre Maribor, Maribor, Slovenia.
12 Dutch Clozapine Collaboration Group, Alkmaar, The Netherlands; Esdege-Reigersdaal, Heerhugowaard, The Netherlands.
13 NHS, Department of Mental Health, G. Mazzini Hospital, Teramo, Italy.
14 University Psychiatric Center Katholieke Universiteit Leuven, Leuvensesteenweg 517, 3070, Kortenberg, Belgium; Department of Neurosciences, Centre for Clinical Psychiatry, Katholieke Universiteit Leuven, Leuven, Belgium; Leuven Brain Institute, Katholieke Universiteit Leuven, Leuven, Belgium; Antwerp Health Law and Ethics Chair, University of Antwerp, Antwerp, Belgium.
15 Department of Internal Medicine, Dermatology and Psychiatry, School of Medicine, University of La Laguna, Canary Islands, Spain.
16 Center for Neuropsychiatric Schizophrenia Research (CNSR), Mental Health Center, Glostrup, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
17 3rd Department of Psychiatry, Division of Neurosciences, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece.
18 Institut de Salut Mental, Hospital del Mar, Barcelona, Spain; Programa Recerca en Salut Mental, Hospital del Mar Research Institute, CIBERSAM, Barcelona; The Donald and Barbara Zucker School of Medicine, Northwell Health, New York, USA.
19 Saint John of God Hospital, Stillorgan, Co. Dublin, Ireland.
20 National Institute of Mental Health, Klecany, Czech Republic;Department of Psychiatry, Charles University, Third Faculty of Medicine, Prague, Czech Republic.
21 Department of Psychiatry, School of Medicine and Medical Science, University College Dublin, Dublin, Ireland; Department of Psychiatry, St Vincent's Hospital Fairview, Dublin, Ireland; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.
22 Nyírő Gyula National Institute of Psychiatry and Addictions, Budapest, Hungary.
23 Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands. GGZ inGeest Mental Health Care, Amsterdam, The Netherlands; Amsterdam Neuroscience (Mood, Anxiety, Psychosis, Stress & Sleep program) and Amsterdam Public Health (Mental Health program) research institutes, Amsterdam, The Netherlands; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands.
24 Pharmacogenomics and drug discovery (GenDeM), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Genomic Medicine Group, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain; Galician Public Foundation of Genomic Medicine (FPGMX), Galician Healthcare Service (SERGAS), Santiago de Compostela, Spain.
25 Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway; Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
26 Mental Health Centre Glostrup, Copenhagen University Hospital, Copenhagen, Denmark.
27 Department of Psychiatry, University College Dublin, Dublin; Department of Psychiatry, St Vincents University Hospital, Dublin, Ireland.
28 Department of psychiatry, Hôpital Universitaire de Bruxelles, Belgium.
29 Center for Drug Sciences, Faculty of Pharmacy, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
30 Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
31 Department of Psychiatry, School of Medicine, University of Zagreb, Zagreb, Croatia; Department for Psychiatry and Psychological Medicine, University Hospital Center Zagreb, Croatia.
32 Department of Physical Medicine and Pharmacology, School of Medicine, Universidad de La Laguna, Canary Islands, Spain; Hospital Universitario de Canarias, Tenerife, Spain.
33 Department of Psychiatry and Psychological Medicine, University Hospital Centre Zagreb; Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.
34 Department of Neuroscience, and Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
35 Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, 70240Kuopio, Finland.
36 Department of Clinical Neuroscience, Karolinska Institutet, and Center for Psychiatry Research, Stockholm City Council, Stockholm, Sweden.
37 School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
38 Neuroscience Center, University of Helsinki, Helsinki, Finland.
39 Mental Health Services Noord-Holland-Noord, Schagen, the Netherlands; Dutch Clozapine Collaboration Group, Alkmaar, the Netherlands.
40 Department of Psychiatry, Medical University of Gdańsk, Gdańsk, Poland.
41 Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
42 Mental Health Services Noord-Holland-Noord, Alkmaar, the Netherlands; Dutch Clozapine Collaboration Group, Alkmaar, the Netherlands.